Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous low-dose antibiotics versus perioperative prophylaxis for temporary double J ureteral stents
ACTRN12612000002886Phase 4Completed
- Sponsor
- Inselspital
- Start
- Mar 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin + clavulanate, trimethoprim + sulfamethoxazole and ciprofloxacin in urinary tract infection (UTI) and ureteral stent-related symptoms (USRS) (2 arms), sponsored by Inselspital. Primary endpoints: Overall rate of urinary tract infection and Overall rate of stent-related symptoms. Started Mar 2005; status: completed.
02
Drugs
amoxicillin + clavulanatetrimethoprim + sulfamethoxazoleciprofloxacin
03
Conditions
urinary tract infection (UTI)ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on ACTRN12612000002886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000002886.